You
are here: Home: CCU 2 | 2003: Al
B Benson, III, MD, FACP: Select publications
Select publications
Calvo E et al. Bi-weekly triplet combination chemotherapy of oxaliplatin,
irinotecan and 5-
FU/leucovorin seems to be feasible and safe in metastatic and adjuvant colorectal
carcinoma. Proc
ASCO 2003;Abstract
1265.
Cassidy J et al. Oxaliplatin (Oxa)/5-FU/LV in first-line metastatic
colorectal cancer followed by
irinotecan: Interim results of the Life Study. Proc ASCO 2003;Abstract
1064.
De Gramont A et al. Oxaliplatin/5-FU/LV in adjuvant colon cancer: Results
of the international
randomized mosaic trial. Proc ASCO 2003;Abstract
1015.
De Gramont A et al. Oxaliplatin/5-FU/LV in adjuvant colon cancer: Safety
results of the international
randomized MOSAIC trial. Proc ASCO 2003;Abstract
525.
Garay CA et al. Randomized trial of bolus plus infusional 5-FU/leucovorin
(LV5FU2) with/without
oxaliplatin (FOLFOX4) after sequential fluoropyrimidine and CPT-11
in the treatment of advanced
colorectal cancer (ACRC). Proc ASCO 2003;Abstract
1019.
Louvet C et al. Gemcitabine versus GEMOX (gemcitabine + oxaliplatin)
in nonresectable pancreatic
adenocarcinoma: Interim results of the GERCOR/GISCAD Intergroup
Phase III. Proc ASCO
2003;Abstract
1004.
Rothenberg M et al. Final results of a Phase III trial of 5-FU/leucovorin
versus oxaliplatin versus the
combination in patients with metastatic colorectal cancer following
irinotecan, 5-FU, and
leucovorin. Proc ASCO 2003;Abstract
1011.
Souglakos J et al. Combination with irinotecan (CPT-11) plus
oxaliplatin (L-OHP) as first-line
treatment in metastatic gastric cancer: A multicenter Phase
II trial. Proc ASCO 2003;Abstract
1288.
|
